Business Wire·Jul 29, 2026, 8:30 AM ET

QT Imaging Appoints Medical Imaging and Digital Health Executive Dr. Julia Albright as Chief Science Officer

QT Imaging Holdings, Inc. appointed Julia Albright, Ph.D., as Chief Science Officer effective July 27, 2026.
Dr. Albright brings over 25 years of experience in medical imaging, digital health, oncology, cloud technologies, & healthcare AI.
She will lead scientific strategy to accelerate innovation in quantitative breast imaging, AI-powered image analysis, & clinical evidence generation.
Her previous roles include Managing Director at Canon Medical Systems USA, senior leadership positions at GE HealthCare, Amazon Web Services, NextGen Healthcare, & CorTechs Labs.
Earlier in her career, she held product leadership roles at Philips, Varian Medical Systems, & Siemens Healthineers.
Dr. Albright holds a Ph.D. from Humboldt University of Berlin, an MBA from Boston University, & a Master of Science from Heidelberg University.
She completed the Stanford LEAD Corporate Innovation program through Stanford Graduate School of Business.
CEO Dr. Raluca Dinu stated Dr. Albright's expertise is vital for evolving QT Imaging from a scanner company to a scalable precision imaging platform.
QT Imaging develops radiation-free imaging systems using low-frequency sound waves & offers the Breast Acoustic CT™ trademark.
The press release includes standard forward-looking statements regarding future business plans, product development, & financial projections.